-
Vascular Health and Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Editorial: Guidelines for choosing drugs in chronic heart failure ||FREE PAPER||
(1679) Views (330) Full article downloads
Author: Reza Tabrizchi
Published Date May 2005
Volume 2005:1(3) Pages 171 - 172
DOI: http://dx.doi.org/10.2147/VHRM.S
Reza Tabrizchi
Division of Basic Medical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St John’s, NL, Canada
In a recent article, Komajda and colleagues (2005) presented data gathered from the Medical Management of Chronic Heart Failure in Europe and its Related Costs (MAHLER) survey in support of the view that adherence to guidelines in treating patients with chronic heart failure is a strong predictor of fewer cardiovascular hospitalizations in clinical practice.
- Join ISVH
Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- The western diet and lifestyle and diseases of civilization
- Stiffness of the large arteries in individuals with and without Down syndrome
- Effects of Azelnidipine plus OlmesaRTAn versus amlodipine plus olmesartan on central blood pressure and left ventricular mass index: the AORTA study
- Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review
